Literature DB >> 2766481

Cloricromene improves survival rate and peritoneal macrophage function in splanchnic artery occlusion shock in rats.

R Sturniolo1, F Squadrito, D Altavilla, G R Trimarchi, M Prosdocimi, A P Caputi.   

Abstract

Splanchnic artery occlusion (SAO) shock, induced by a transient occlusion of splanchnic arteries for 45 min, was performed in male rats, treated with vehicle or cloricromene, a coumarin derivative, 15 min before surgery. Survival rate, plasma levels of myocardial depressant factor (MDF), macrophage phagocytosis and killing of Candida albicans, and thromboxane B2 (TxB2) synthesis by peritoneal macrophages were evaluated. Of the SAO-shocked animals, 10% survived for 6 hr after the release of the occlusion of the splanchnic arteries, whereas none of the sham-shocked rats died. Peritoneal macrophages of shocked animals exhibited decreased phagocytosis (24.7 +/- 2.7%) and killing (8.0 +/- 2.1%) and increased TxB2 levels (3.23 +/- 0.27 ng/ml) with respect to those collected from sham-shocked animals (phagocytosis 48.8 +/- 3.0%; killing 16.5 +/- 2.4%; TxB2 0.30 +/- 0.18 ng/ml). MDF was also increased (114.3 +/- 21.5 U/ml) compared with sham-shocked animals (31.5 +/- 3.7 U/ml). Cloricromene, given intravenously (i.v.) at doses of 1, 2, and 4 mg/kg, significantly increased survival rate and lowered MDF in shocked rats. Lower doses (0.25 and 0.5 mg/kg/i.v.) were without effect. Doses that were able to reduce mortality partially reverted shock-induced macrophage impairment of phagocytosis, killing of C. albicans, and TxB2 synthesis. In addition, cloricromene (5, 10, and 25 microM) added in vitro to peritoneal macrophages, collected from shocked rats, significantly enhanced their phagocytic activity depressed by shock.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2766481

Source DB:  PubMed          Journal:  Circ Shock        ISSN: 0092-6213


  9 in total

1.  Cloricromene, a coumarine derivative, protects against collagen-induced arthritis in Lewis rats.

Authors:  S Cuzzocrea; E Mazzon; C Bevilaqua; G Costantino; D Britti; G Mazzullo; A De Sarro; A P Caputi
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

2.  Monocytes and lymphocytes as active participants in the pathogenesis of experimental shock.

Authors:  D Altavilla; F Squadrito; L Ammendolia; G Squadrito; G M Campo; P Canale; M Ioculano; C Musolino; A Alonci; A Sardella; G Urna; A Saitta; A P Caputi
Journal:  Inflamm Res       Date:  1996-08       Impact factor: 4.575

3.  Cloricromene, a coumarine derivative, reduced the development of periodontitis in rats.

Authors:  Carmelo Muià; Emanuela Mazzon; Daniele Zito; Daniele Maiere; Domenico Britti; Concetta Crisafulli; Giacomo Oteri; Giancarlo Cordasco; Salvatore Cuzzocrea
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-03-28       Impact factor: 3.000

4.  TCV-309, a novel platelet activating factor antagonist, inhibits leukocyte accumulation and protects against splanchnic artery occlusion shock.

Authors:  P Canale; F Squadrito; D Altavilla; M Ioculano; B Zingarelli; G M Campo; G Urna; A Sardella; G Squadrito; A P Caputi
Journal:  Agents Actions       Date:  1994-10

5.  Dissociation of the anti-ischaemic effects of cloricromene from its anti-platelet activity.

Authors:  P S Lidbury; R Cirillo; J R Vane
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

6.  Contribution of intercellular adhesion molecule 1 (ICAM-1) to the pathogenesis of splanchnic artery occlusion shock in the rat.

Authors:  F Squadrito; D Altavilla; P Canale; M P Ioculano; G M Campo; L Ammendolia; G Squadrito; A Saitta; G Calapai; A P Caputi
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

7.  Improved survival and reversal of endothelial dysfunction by the 21-aminosteroid, U-74389G in splanchnic ischaemia-reperfusion injury in the rat.

Authors:  F Squadrito; D Altavilla; L Ammendolia; G Squadrito; G M Campo; A Sperandeo; P Canale; M Ioculano; A Saitta; A P Caputi
Journal:  Br J Pharmacol       Date:  1995-06       Impact factor: 8.739

8.  Participation of tumour necrosis factor and nitric oxide in the mediation of vascular dysfunction in splanchnic artery occlusion shock.

Authors:  F Squadrito; D Altavilla; P Canale; M Ioculano; G M Campo; L Ammendolia; M Ferlito; B Zingarelli; G Squadrito; A Saitta
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

9.  Multiple actions of the coumarine derivative cloricromene and its protective effects on ischemic brain injury.

Authors:  G Calapai; F Squadrito; A Rizzo; M C Marciano; G M Campo; A P Caputi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-02       Impact factor: 3.000

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.